REBECCA LAMBO: Open Payments
NPI 1144626995 · WAUCONDA, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,628 in 99 payments from 19 companies in 2025. Trend: 2023 $738 · 2024 $1,157 · 2025 $1,628
Food & beverage: $1,628
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 37 | $430 |
| Lilly USA, LLC | 13 | $205 |
| PFIZER INC. | 9 | $172 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 7 | $117 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $91 |
| Exact Sciences Corporation | 3 | $82 |
| AstraZeneca Pharmaceuticals LP | 5 | $79 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $53 |
| Axsome Therapeutics, Inc. | 2 | $53 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $51 |
Products named: VRAYLAR, NURTEC ODT, QULIPTA, XIFAXAN, JARDIANCE, MOUNJARO, TRINTELLIX, UBRELVY.
Industry payments across IL — which companies pay providers there.
